Victor Golmer/iStock Editorial via Getty Images
Grifols (NASDAQ:GRFS) announced Friday that its board of directors unanimously adopted a series of measures to facilitate a possible go-private transaction involving its founding family and asset manager, Brookfield Fund.
After a meeting of its board members, the company said it decided to appoint a committee comprising entirely independent directors to evaluate the transaction’s progress.
The board has also adopted a resolution to give Brookfield access to the company’s information relevant to the takeover bid.
Directors related to the Grifols (GRFS) family, namely Raimon Grifols Roura, Victor Grifols Deu, Albert Grifols Coma-Cros, and Tomás Dagá Gelabert, didn’t attend the meeting due to a potential conflict of interest.
Early this week, shares of the Spanish plasma therapeutics company surged after announcing a preliminary offer from the Grifols family and Brookfield, which it said would lead to its delisting.